These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3296725)

  • 1. Efficacy of oral and intravenous indecainide in ventricular arrhythmias.
    Nestico PF; Morganroth J; Horowitz LN; Mulhern C
    Am J Cardiol; 1987 Jun; 59(15):1332-6. PubMed ID: 3296725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indecainide for treatment of ventricular ectopic depolarizations: efficacy, pharmacokinetics, hemodynamic effects and safety.
    Salerno DM; Krejci J; Granrud G; Hodges M
    J Am Coll Cardiol; 1988 Apr; 11(4):843-50. PubMed ID: 3351153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiarrhythmic effects of oral indecainide in patients with ventricular tachyarrhythmias.
    Macina G; Turitto G; Stavens C; Fontaine J; Hariman R; Ursell S; el-Sherif N
    Clin Cardiol; 1987 Jun; 10(6):357-61. PubMed ID: 3594958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiarrhythmic and hemodynamic evaluation of indecainide and procainamide in nonsustained ventricular tachycardia.
    Pratt CM; Francis MJ; Seals AA; Zoghbi W; Young JB
    Am J Cardiol; 1990 Jul; 66(1):68-74. PubMed ID: 2193498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indecainide compared with quinidine for chronic stable ventricular arrhythmias secondary to coronary artery disease or to cardiomyopathy.
    Giardina EG; Zaim S; Saroff AL; Kirschenbaum M
    Am J Cardiol; 1987 Sep; 60(7):584-9. PubMed ID: 2442993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of indecainide in patients with left ventricular dysfunction.
    Giardina EV; Saroff AL; Schneider M
    Clin Pharmacol Ther; 1990 Nov; 48(5):582-9. PubMed ID: 2225716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indecainide: effects on arrhythmias, electrophysiology, and cardiovascular dynamics.
    Holland DR; Lacefield WB; Gonzales CR; Johnston SR; Turk JA
    J Cardiovasc Pharmacol; 1989 Sep; 14(3):454-61. PubMed ID: 2476626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive evaluation of indecainide for serious ventricular tachyarrhythmia.
    Podrid PJ; Hohnloser S; Lown B
    Am J Cardiol; 1988 Apr; 61(10):764-9. PubMed ID: 2451415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Encainide for ventricular arrhythmias: placebo-controlled and standard comparison trials.
    Morganroth J
    Am J Cardiol; 1986 Aug; 58(5):74C-82C. PubMed ID: 3092623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of flecainide in the therapy of chronic ventricular arrhythmia using the acute oral load method].
    Schwartz PJ; Facchini M; Bonazzi O; Cuspidi C; Priori S; Varisco T; Zuanetti G
    G Ital Cardiol; 1985 Mar; 15(3):273-82. PubMed ID: 4018465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiarrhythmic effects of indecainide in a drug-resistant population with ventricular tachycardia at programmed electrical stimulation.
    Miura DS; Wynn J; Keefe D; Laux B; Somberg JC
    Am Heart J; 1987 Jan; 113(1):65-9. PubMed ID: 3799443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short- and long-term therapeutic efficacy of quinidine sulfate for the treatment of chronic ventricular arrhythmias.
    Panidis I; Morganroth J
    J Clin Pharmacol; 1982; 22(8-9):379-84. PubMed ID: 6752212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous atenolol for ventricular arrhythmias.
    Morganroth J
    Am J Cardiol; 1986 Sep; 58(6):499-502. PubMed ID: 3529912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recainam dose titration and pharmacokinetics in patients with resistant arrhythmias.
    Davies RF; Lineberry MD; Funck-Brentano C; Echt DS; Lee JT; Capuzzi DM; Roden DM; Woosley RL
    Clin Pharmacol Ther; 1989 Sep; 46(3):324-34. PubMed ID: 2673622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of oral propafenone in chronic ventricular arrhythmias: a placebo controlled cross-over exercise study.
    Härtel G
    Eur Heart J; 1985 Feb; 6(2):123-9. PubMed ID: 3891347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacy and safety of oral mexiletine and quinidine in benign or potentially lethal ventricular arrhythmias.
    Morganroth J
    Am J Cardiol; 1987 Dec; 60(16):1276-81. PubMed ID: 3318368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral flecainide acetate for the treatment of ventricular arrhythmias.
    Anderson JL; Stewart JR; Perry BA; Van Hamersveld DD; Johnson TA; Conard GJ; Chang SF; Kvam DC; Pitt B
    N Engl J Med; 1981 Aug; 305(9):473-7. PubMed ID: 7019711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term and long-term treatment with propafenone: determinants of arrhythmia suppression, persistence of efficacy, arrhythmogenesis, and side effects in patients with symptoms.
    Zehender M; Hohnloser S; Geibel A; Furtwängler A; Olschewski M; Meinertz T; Just H
    Br Heart J; 1992 Jun; 67(6):491-7. PubMed ID: 1622701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative efficacy and safety of oral tocainide and quinidine for benign and potentially lethal ventricular arrhythmias.
    Morganroth J; Oshrain C; Steele PP
    Am J Cardiol; 1985 Oct; 56(10):581-5. PubMed ID: 3931448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral propafenone in the suppression of chronic stable ventricular arrhythmias.
    Schamroth L; Myburgh DP; Schamroth CL; Scholtz ME; Pincus DR; Kawalsky DL
    Chest; 1985 Apr; 87(4):448-51. PubMed ID: 3884286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.